Novalis Biotech aims for January second close for new €25m fund
Novalis Biotech Incubation, a Belgian seed-stage biotech investor, is fundraising for a second, €25m investment vehicle, according to co-founder and managing director Jan Van den Berghe.
More on Funds
Certior holds first close on €35m for special opportunities fund
Fund has a target of €75m and is due to hold a final close in May 2021
TriSpan Opportunities Fund II holds first close
Fund focuses on investment opportunities in the lower-mid-market across North America and Europe
Andreessen Horowitz raises $4.5bn across two funds
VC raises $1.3bn for its seventh early-stage fund and $3.2bn for its second growth fund
HIG Europe Capital Partners III closes on €1.1bn
Fund invests in buyouts, recapitalisations and corporate carve-outs of European businesses
Latest News
Index Ventures leads €25m round for Ankorstore
B2B marketplace for brands and independent retailers is also backed by GFC, Alven and Aglaé
Monterro buys SaaS company TimeEdit
GP has reportedly acquired a stake of around 75% for almost SEK 100m (€9.8m)
Quadrivio backs EPI
GP invests in the company via its Industry 4.0 fund, which was launched with a €300m target in 2018
Investindustrial buys Campus Training
GP intends to create a platform for new acquisitions across the professional education sector in Spain